A new gene editing therapy for sickle cell disease and β-thalassaemia showed benefits for more than 90% of patients, according to the final results of the first clinical trials.
Exagamglogene autotemcel (exa-cel) received regulatory approval in th...
4 months ago
The next British government should invest in leukaemia research as a priority, campaigners have said.
Plans for research should be part of a Cancer Strategy that should be unveiled within a year of the forthcoming election, according to Leukaemia...
4 months ago
